Phase 3 Atrial fibrillation trials recruiting now

All Atrial fibrillation trials, every phase

Other phases for Atrial fibrillation

Phase 3 Atrial fibrillation trials

• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 106 locations
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 187 locations
• Avoiding Anticoagulation After IntraCerebral Haemorrhage
  NCT03243175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery
  NCT06722196 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial
  NCT07738523 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Colchicine After Electrocardioversion for Atrial Fibrillation
  NCT05890664 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
  NCT06376916 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
  NCT05174052 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
  NCT06715449 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
  NCT05293080 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
  NCT05549752 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 3 locations
• Pulsed-field Ablation Vs. Sham Ablation to Treat AF
  NCT05717725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care
  NCT07187570 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · 7 locations
• ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
  NCT06716021 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
  NCT05852704 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
  NCT06499857 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
  NCT05841056 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
  NCT05679024 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 34 locations
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
  NCT07430956 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 35 locations
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · 789 locations
• The COLchicine and Atrial FIBrillation Trial
  NCT05928728 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  NCT05836987 · Phase: Phase 3 · Ages: 22 Years to 85 Years · Sex: All (male and female) · 93 locations
• Thrombolysis in Factor Xa-inhibitors Trial
  NCT06878066 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.